PharmacoEconomics

The Single Market for Pharmaceuticals in the European Union in Light of European Court of Justice Rulings
pp. 523-532(10)
Author: Kanavos P.

Stratified Administration of Serotonin 5-HT Receptor Antagonists (Setrons) for Chemotherapy-Induced Emesis: Economic Implications
pp. 533-556(24)
Authors: Sanchez L.A.; Holdsworth M.; Bartel S.B.

Effectiveness of Eletriptan in Reducing Time Loss Caused by Migraine Attacks
pp. 557-566(10)
Authors: Wells N.E.J.; Steiner T.J.

Olanzapine versus Risperidone: A Prospective Comparison of Clinical and Economic Outcomes in Schizophrenia
pp. 567-579(13)
Authors: Edgell E.T.; Andersen S.W.; Johnstone B.M.; Dulisse B.; Revicki D.; Breier A.

Association between Abciximab and Length of Stay in Intensive Care for Patients Undergoing Percutaneous Coronary Intervention: A 2-Stage Econometric Model in a Naturalistic Setting
pp. 581-589(9)
Authors: Lage M.J.; Barber B.L.; Bala M.; McCollam P.L.; Ball D.E.

Inhaled Salmeterol/Fluticasone Propionate Combination: A Pharmacoeconomic Review of its Use in the Management of Asthma
pp. 591-608(18)
Authors: Markham A.; Adkins J.C.

Potential Savings in the Cost of Caring for Alzheimer's Disease: Treatment with Rivastigmine
pp. 609-612(4)
Authors: Linkins K.W.; Lloyd J.R.; Hjelmstad G.O.; Strausbaugh H.J.

Potential Savings in the Cost of Caring for Alzheimer's Disease: Treatment with Rivastigmine
pp. 609-612(4)
Authors: Hauber A.B.; Mauskopf J.A.; Snyder E.H.